Screening of and mechanism underlying the action of serum- and glucocorticoid-regulated kinase 3-targeted drugs against estrogen receptor-positive breast cancerDuanfang Zhou, Weiying Zhou, Huan Zhang et al.|European Journal of Pharmacology|2022Cited by 6
SGK3 promotes estrogen receptor‐positive breast cancer proliferation by activating STAT3/ZMIZ2 pathway to stabilise β‐cateninLie Yuan, Weiying Zhou, Yongqing Cai et al.|British Journal of Pharmacology|2025Cited by 1